Current Illinois CancerCare Clinical Trals

Metastatic


A032001

Testing the Addition of the Anti-cancer Drug, Cabozantinib, to the Usual Immunotherapy Treatment, Avelumab, in Patients With Metastatic Urothelial Cancer, MAIN-CAV Study


A032002 (Suspended)

Immunotherapy With or Without Radiation Therapy for Metastatic Urothelial Cancer (Suspended)


Search Again